Financings Of The Fortnight: Exelixis Follows Horrible Year With Successful Stock Offering
This article was originally published in The Pink Sheet Daily
News on recent financings by Aerie Pharmaceuticals, Nimbus Discovery, BioCryst and Omthera Pharmaceuticals.
You may also be interested in...
Belgian start-up raises record-breaking €18 million A round to take rho kinase inhibitor glaucoma candidate to clinical proof-of-concept.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.